Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedNov 11, 2020Lansoprazole Delayed-Release Orally Disintegrating Tablets 15 mgFailed Dissolution SpecificationZydus Pharmaceuticals (USA) Inc · D-0074-2021Class IIOngoingNov 11, 2020Metformin Hydrochloride Extended-Release TabletsCGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake levelNostrum Laboratories Inc · D-0068-2021Class IIOngoingNov 11, 2020Metformin Hydrochloride Extended-Release TabletsCGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake levelNostrum Laboratories Inc · D-0067-2021Class IIITerminatedNov 11, 2020Olanzapine Orally Disintegrating TabletsSubpotentJubilant Cadista Pharmaceuticals, Inc. · D-0066-2021Class IIITerminatedNov 11, 2020Fluent Children's Fever + Pain IBUPROFEN Oral Suspension USP 100 mg per 5 mL Pain Reliever/Fever ReducerLabeling Not Elsewhere Classified: Ibuprofen Oral Suspension is missing dosing cups.Aurobindo Pharma USA Inc. · D-0065-2021Class IIITerminatedNov 11, 2020Fluocinonide Ointment USP 0.05%Failed Impurities/Degradation - Out-of-specification results for Fluocinolone Acetonide impurity.Teligent Pharma, Inc. · D-0064-2021Class IITerminatedNov 11, 2020Time-Cap LabsCGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake levelMarksans Pharma Limited · D-0062-2021Class IITerminatedNov 11, 2020Time-Cap LabsCGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake levelMarksans Pharma Limited · D-0061-2021Class IITerminatedNov 11, 2020metformin HCL ER 750 mgCGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)PD-Rx Pharmaceuticals, Inc. · D-0060-2021Class IITerminatedNov 11, 2020metformin HCL ER 500 mgCGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)PD-Rx Pharmaceuticals, Inc. · D-0059-2021Class IITerminatedNov 11, 2020Metformin HCL E/R 500 mgCGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)Direct Rx · D-0058-2021Class IIOngoingNov 11, 2020Metformin Hydrochloride Extended-Release TabletsCGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)Denton Pharma, Inc. · D-0057-2021Class IIOngoingNov 11, 2020Metformin Hydrochloride Extended-Release Tablets USP 750 mgCGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)Denton Pharma, Inc. · D-0056-2021Class IITerminatedNov 11, 2020Chlorhexidine Gluconate 20% 0012 MedichemDiscoloration.Medichem S.A. · D-0055-2021Class IITerminatedNov 4, 2020N-A-C (N-Acetyl-L-CysteineMislabeling of SUS (N-A-C Sustain 600 mg 100 tab) with N-A-C N-Acetyl-L-Cysteine 500 mg, 100 cap.Jarrow Formulas Inc · D-0302-2021Class IITerminatedNov 4, 2020Hydrocortisone butyrate CreamSUBPOTENT DRUGBausch Health Companies, Inc. · D-0054-2021Class IITerminatedNov 4, 2020CatapresAn extraneous peak was observed for dissolution testing.Boehringer Ingelheim Pharmaceuticals, Inc. · D-0053-2021Class IITerminatedNov 4, 2020CatapresAn extraneous peak was observed for dissolution testing.Boehringer Ingelheim Pharmaceuticals, Inc. · D-0052-2021Class IITerminatedNov 4, 2020CatapresAn extraneous peak was observed for dissolution testing.Boehringer Ingelheim Pharmaceuticals, Inc. · D-0051-2021Class IITerminatedNov 4, 2020Metformin Hydrochloride Extended Release 750 mgCGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)RemedyRepack Inc. · D-0050-2021Class IIITerminatedOct 28, 2020Candesartan Cilexetil and Hydrochlorothiazide TabletsOut-of-specification organic impurity results obtained during routine stability testing.Mylan Pharmaceuticals Inc. · D-0049-2021Class IIITerminatedOct 28, 2020Dextroamphetamine SaccharateLabeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.ANI Pharmaceuticals, Inc. · D-0048-2021Class IIITerminatedOct 28, 2020Dextroamphetamine SaccharateLabeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.ANI Pharmaceuticals, Inc. · D-0047-2021Class IIITerminatedOct 28, 2020Dextroamphetamine SaccharateLabeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.ANI Pharmaceuticals, Inc. · D-0046-2021Class IIITerminatedOct 28, 2020Dextroamphetamine SaccharateLabeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.ANI Pharmaceuticals, Inc. · D-0045-2021Class IIITerminatedOct 28, 2020Dextroamphetamine SaccharateLabeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.ANI Pharmaceuticals, Inc. · D-0044-2021Class IIITerminatedOct 28, 2020Dextroamphetamine SaccharateLabeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.ANI Pharmaceuticals, Inc. · D-0043-2021Class IIITerminatedOct 28, 2020DesfluraneDEFECTIVE CONTAINER: Desflurane Liquid for Inhalation 240 mL may be leaking.eVenus Pharmaceutical Laboratories · D-0042-2021Class IIOngoingOct 28, 2020Killz Germz Hand SanitizerSub-Potent Drug; Killz GERMz was recalled due to sub-potent results. Testing revealed ethanol levels as low as 62% while labelled claim is 70%.Genesis Partnership Company SA · D-0041-2021Class IIOngoingOct 28, 2020Killz Germz Hand SanitizerSub-Potent Drug; Killz GERMz was recalled due to sub-potent results. Testing revealed ethanol levels as low as 62% while labelled claim is 70%.Genesis Partnership Company SA · D-0040-2021Class IIOngoingOct 28, 2020Genesis Hand Sanitizer GelCGMP Deviations: hand sanitizers were recalled because they were manufactured in the same facility as another hand sanitizer product with sub-potent ethanol levels.Genesis Partnership Company SA · D-0039-2021Class IIOngoingOct 28, 2020Genesis Hand Sanitizer GelCGMP Deviations: hand sanitizers were recalled because they were manufactured in the same facility as another hand sanitizer product with sub-potent ethanol levels.Genesis Partnership Company SA · D-0038-2021Class IIOngoingOct 28, 2020Panagel Hand SanitizerCGMP Deviations: hand sanitizers were recalled because they were manufactured in the same facility as another hand sanitizer product with sub-potent ethanol levels.Genesis Partnership Company SA · D-0037-2021Class ITerminatedOct 28, 2020NP Thyroid 120Subpotent Drug: FDA analysis found these products to be less than the labeled claim for the levothyroxine (T4) portion of the product.Acella Pharmaceuticals, LLC · D-0036-2021Class ITerminatedOct 28, 2020NP Thyroid 15Subpotent Drug: FDA analysis found these products to be less than the labeled claim for the levothyroxine (T4) portion of the product.Acella Pharmaceuticals, LLC · D-0035-2021Class ITerminatedOct 21, 2020Smart Care HAND SANITIZERLabeling: Not Elsewhere Classified. Container packaging is made, formed or filled to be misleading, resembling food and drink pouchesAshtel Studios, Inc. · D-0098-2021Class IIITerminatedOct 21, 2020CystaranSubpotent Drug: Product testing identified a decreased level of the active ingredient, Cysteamine HCl.Leadiant Biosciences, Inc. · D-0034-2021Class IIITerminatedOct 14, 2020NYSTATIN ORAL SUSPENSIONFailed Impurties/Degradation Specifications: out of specification results for an impurity for one lotVistaPharm, Inc. · D-0019-2021Class IITerminatedOct 14, 2020Losartan Potassium 100 mgCGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level...Direct Rx · D-0018-2021Class IITerminatedOct 14, 2020Ranitidine 300 mgCGMP Deviations: Presence of NDMA impurity detected in product.Direct Rx · D-0017-2021

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.